![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: POLD1 |
Gene summary for POLD1 |
![]() |
Gene information | Species | Human | Gene symbol | POLD1 | Gene ID | 5424 |
Gene name | DNA polymerase delta 1, catalytic subunit | |
Gene Alias | CDC2 | |
Cytomap | 19q13.33 | |
Gene Type | protein-coding | GO ID | GO:0000731 | UniProtAcc | A0A024R4F4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
5424 | POLD1 | LZE7T | Human | Esophagus | ESCC | 2.93e-07 | 2.31e-01 | 0.0667 |
5424 | POLD1 | LZE6T | Human | Esophagus | ESCC | 5.85e-03 | 1.86e-01 | 0.0845 |
5424 | POLD1 | P1T-E | Human | Esophagus | ESCC | 3.41e-03 | 1.85e-01 | 0.0875 |
5424 | POLD1 | P2T-E | Human | Esophagus | ESCC | 9.56e-08 | 1.77e-01 | 0.1177 |
5424 | POLD1 | P4T-E | Human | Esophagus | ESCC | 8.83e-05 | 1.65e-01 | 0.1323 |
5424 | POLD1 | P5T-E | Human | Esophagus | ESCC | 7.90e-03 | 9.51e-02 | 0.1327 |
5424 | POLD1 | P8T-E | Human | Esophagus | ESCC | 4.44e-08 | 1.86e-01 | 0.0889 |
5424 | POLD1 | P10T-E | Human | Esophagus | ESCC | 4.12e-11 | 2.10e-01 | 0.116 |
5424 | POLD1 | P11T-E | Human | Esophagus | ESCC | 6.89e-07 | 2.47e-01 | 0.1426 |
5424 | POLD1 | P12T-E | Human | Esophagus | ESCC | 4.17e-05 | 1.53e-01 | 0.1122 |
5424 | POLD1 | P15T-E | Human | Esophagus | ESCC | 1.13e-07 | 2.28e-01 | 0.1149 |
5424 | POLD1 | P16T-E | Human | Esophagus | ESCC | 4.41e-07 | 1.22e-01 | 0.1153 |
5424 | POLD1 | P17T-E | Human | Esophagus | ESCC | 2.78e-04 | 2.51e-01 | 0.1278 |
5424 | POLD1 | P20T-E | Human | Esophagus | ESCC | 1.87e-03 | 6.32e-02 | 0.1124 |
5424 | POLD1 | P21T-E | Human | Esophagus | ESCC | 4.31e-06 | 1.05e-01 | 0.1617 |
5424 | POLD1 | P22T-E | Human | Esophagus | ESCC | 8.84e-05 | 1.01e-01 | 0.1236 |
5424 | POLD1 | P23T-E | Human | Esophagus | ESCC | 3.27e-09 | 1.30e-01 | 0.108 |
5424 | POLD1 | P26T-E | Human | Esophagus | ESCC | 1.76e-12 | 2.29e-01 | 0.1276 |
5424 | POLD1 | P27T-E | Human | Esophagus | ESCC | 1.97e-10 | 2.22e-01 | 0.1055 |
5424 | POLD1 | P28T-E | Human | Esophagus | ESCC | 9.02e-11 | 1.94e-01 | 0.1149 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0070482 | Colorectum | AD | response to oxygen levels | 99/3918 | 347/18723 | 4.29e-04 | 4.82e-03 | 99 |
GO:0003158 | Colorectum | AD | endothelium development | 44/3918 | 136/18723 | 1.20e-03 | 1.07e-02 | 44 |
GO:0045446 | Colorectum | AD | endothelial cell differentiation | 39/3918 | 118/18723 | 1.42e-03 | 1.22e-02 | 39 |
GO:0010876 | Colorectum | AD | lipid localization | 120/3918 | 448/18723 | 1.59e-03 | 1.33e-02 | 120 |
GO:0006869 | Colorectum | AD | lipid transport | 108/3918 | 398/18723 | 1.67e-03 | 1.39e-02 | 108 |
GO:0001666 | Colorectum | AD | response to hypoxia | 86/3918 | 307/18723 | 1.77e-03 | 1.46e-02 | 86 |
GO:0036293 | Colorectum | AD | response to decreased oxygen levels | 88/3918 | 322/18723 | 3.42e-03 | 2.49e-02 | 88 |
GO:00704821 | Colorectum | SER | response to oxygen levels | 79/2897 | 347/18723 | 1.99e-04 | 3.64e-03 | 79 |
GO:00016661 | Colorectum | SER | response to hypoxia | 69/2897 | 307/18723 | 7.07e-04 | 9.39e-03 | 69 |
GO:00362931 | Colorectum | SER | response to decreased oxygen levels | 71/2897 | 322/18723 | 1.04e-03 | 1.22e-02 | 71 |
GO:00704822 | Colorectum | MSS | response to oxygen levels | 85/3467 | 347/18723 | 3.08e-03 | 2.34e-02 | 85 |
GO:00031581 | Colorectum | MSS | endothelium development | 38/3467 | 136/18723 | 4.53e-03 | 3.19e-02 | 38 |
GO:00016662 | Colorectum | MSS | response to hypoxia | 75/3467 | 307/18723 | 5.56e-03 | 3.78e-02 | 75 |
GO:00108761 | Colorectum | MSS | lipid localization | 104/3467 | 448/18723 | 6.76e-03 | 4.38e-02 | 104 |
GO:00454461 | Colorectum | MSS | endothelial cell differentiation | 33/3467 | 118/18723 | 7.66e-03 | 4.81e-02 | 33 |
GO:00704823 | Colorectum | FAP | response to oxygen levels | 77/2622 | 347/18723 | 2.08e-05 | 5.05e-04 | 77 |
GO:00016663 | Colorectum | FAP | response to hypoxia | 68/2622 | 307/18723 | 6.53e-05 | 1.25e-03 | 68 |
GO:00362932 | Colorectum | FAP | response to decreased oxygen levels | 70/2622 | 322/18723 | 9.49e-05 | 1.61e-03 | 70 |
GO:00068691 | Colorectum | FAP | lipid transport | 81/2622 | 398/18723 | 2.84e-04 | 3.76e-03 | 81 |
GO:0030856 | Colorectum | FAP | regulation of epithelial cell differentiation | 36/2622 | 154/18723 | 1.16e-03 | 1.11e-02 | 36 |
Page: 1 2 3 4 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0342022 | Esophagus | ESCC | Nucleotide excision repair | 54/4205 | 63/8465 | 2.01e-09 | 2.17e-08 | 1.11e-08 | 54 |
hsa034104 | Esophagus | ESCC | Base excision repair | 38/4205 | 44/8465 | 3.59e-07 | 2.62e-06 | 1.34e-06 | 38 |
hsa030304 | Esophagus | ESCC | DNA replication | 32/4205 | 36/8465 | 7.71e-07 | 5.06e-06 | 2.59e-06 | 32 |
hsa034304 | Esophagus | ESCC | Mismatch repair | 21/4205 | 23/8465 | 2.85e-05 | 1.35e-04 | 6.90e-05 | 21 |
hsa0342032 | Esophagus | ESCC | Nucleotide excision repair | 54/4205 | 63/8465 | 2.01e-09 | 2.17e-08 | 1.11e-08 | 54 |
hsa0341011 | Esophagus | ESCC | Base excision repair | 38/4205 | 44/8465 | 3.59e-07 | 2.62e-06 | 1.34e-06 | 38 |
hsa0303011 | Esophagus | ESCC | DNA replication | 32/4205 | 36/8465 | 7.71e-07 | 5.06e-06 | 2.59e-06 | 32 |
hsa0343011 | Esophagus | ESCC | Mismatch repair | 21/4205 | 23/8465 | 2.85e-05 | 1.35e-04 | 6.90e-05 | 21 |
hsa034204 | Oral cavity | OSCC | Nucleotide excision repair | 49/3704 | 63/8465 | 3.48e-08 | 2.91e-07 | 1.48e-07 | 49 |
hsa03030 | Oral cavity | OSCC | DNA replication | 31/3704 | 36/8465 | 1.70e-07 | 1.19e-06 | 6.03e-07 | 31 |
hsa03410 | Oral cavity | OSCC | Base excision repair | 32/3704 | 44/8465 | 9.11e-05 | 3.25e-04 | 1.65e-04 | 32 |
hsa03430 | Oral cavity | OSCC | Mismatch repair | 19/3704 | 23/8465 | 1.55e-04 | 5.34e-04 | 2.72e-04 | 19 |
hsa0342011 | Oral cavity | OSCC | Nucleotide excision repair | 49/3704 | 63/8465 | 3.48e-08 | 2.91e-07 | 1.48e-07 | 49 |
hsa030301 | Oral cavity | OSCC | DNA replication | 31/3704 | 36/8465 | 1.70e-07 | 1.19e-06 | 6.03e-07 | 31 |
hsa034101 | Oral cavity | OSCC | Base excision repair | 32/3704 | 44/8465 | 9.11e-05 | 3.25e-04 | 1.65e-04 | 32 |
hsa034301 | Oral cavity | OSCC | Mismatch repair | 19/3704 | 23/8465 | 1.55e-04 | 5.34e-04 | 2.72e-04 | 19 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
POLD1 | SNV | Missense_Mutation | novel | c.425A>T | p.His142Leu | p.H142L | protein_coding | deleterious(0.05) | possibly_damaging(0.598) | TCGA-77-7465-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
POLD1 | SNV | Missense_Mutation | novel | c.1331G>T | p.Arg444Leu | p.R444L | protein_coding | deleterious(0) | possibly_damaging(0.836) | TCGA-NC-A5HD-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
POLD1 | SNV | Missense_Mutation | novel | c.1165N>C | p.Asp389His | p.D389H | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-CR-5247-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | paclitaxel | CR | |
POLD1 | SNV | Missense_Mutation | rs748471297 | c.14N>A | p.Arg5Gln | p.R5Q | protein_coding | deleterious(0.02) | possibly_damaging(0.457) | TCGA-CR-6484-01 | Oral cavity | head & neck squamous cell carcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | SD | |
POLD1 | SNV | Missense_Mutation | rs781327088 | c.1946N>A | p.Arg649Gln | p.R649Q | protein_coding | tolerated(0.73) | benign(0.019) | TCGA-CV-A45T-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
POLD1 | SNV | Missense_Mutation | novel | c.1180N>G | p.Thr394Ala | p.T394A | protein_coding | deleterious(0.03) | possibly_damaging(0.824) | TCGA-F7-A624-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
POLD1 | SNV | Missense_Mutation | novel | c.2309N>T | p.Gly770Val | p.G770V | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-HD-8224-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cetuximab | PD | |
POLD1 | SNV | Missense_Mutation | rs754832710 | c.2702G>A | p.Arg901His | p.R901H | protein_coding | deleterious(0) | benign(0.429) | TCGA-XK-AAIW-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 9 | Unknown | Unknown | PD | |
POLD1 | SNV | Missense_Mutation | c.2567N>G | p.Glu856Gly | p.E856G | protein_coding | deleterious(0) | possibly_damaging(0.744) | TCGA-B7-5816-01 | Stomach | stomach adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
POLD1 | SNV | Missense_Mutation | novel | c.700G>A | p.Ala234Thr | p.A234T | protein_coding | tolerated(0.39) | benign(0.015) | TCGA-BR-4368-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
5424 | POLD1 | DNA DIRECTED RNA POLYMERASE, DRUGGABLE GENOME, CLINICALLY ACTIONABLE, DNA REPAIR, ENZYME | inhibitor | CHEMBL1637 | GEMCITABINE HYDROCHLORIDE | |
5424 | POLD1 | DNA DIRECTED RNA POLYMERASE, DRUGGABLE GENOME, CLINICALLY ACTIONABLE, DNA REPAIR, ENZYME | inhibitor | CHEMBL1750 | CLOFARABINE | |
5424 | POLD1 | DNA DIRECTED RNA POLYMERASE, DRUGGABLE GENOME, CLINICALLY ACTIONABLE, DNA REPAIR, ENZYME | inhibitor | CHEMBL803 | CYTARABINE | |
5424 | POLD1 | DNA DIRECTED RNA POLYMERASE, DRUGGABLE GENOME, CLINICALLY ACTIONABLE, DNA REPAIR, ENZYME | HYMENOIC ACID | HYMENOIC ACID | 18364258 | |
5424 | POLD1 | DNA DIRECTED RNA POLYMERASE, DRUGGABLE GENOME, CLINICALLY ACTIONABLE, DNA REPAIR, ENZYME | inhibitor | CHEMBL1096882 | FLUDARABINE PHOSPHATE |
Page: 1 |